MEK INHIBITOR-ASSOCIATED SEROUS RETINOPATHY

MEK INHIBITOR-ASSOCIATED SEROUS RETINOPATHY was reported 4 times

MEK INHIBITOR-ASSOCIATED SEROUS RETINOPATHY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 COBIMETINIB 2 0.0005
1 VEMURAFENIB 2 0.0002
2 TRAMETINIB 2 0.0001
3 DABRAFENIB 1 0.0000
4 CIPROFLOXACIN TABLETS 1 0.0000
5 CIPROFLOXACIN HYDROCHLORIDE 1 0.0000
6 HYDROCHLOROTHIAZIDE 1 0.0000
7 METFORMIN ER 500 MG 1 0.0000
8 PREDNISONE 1 0.0000